company background image
002317 logo

Guangdong Zhongsheng Pharmaceutical XSEC:002317 Stock Report

Last Price

CN¥10.99

Market Cap

CN¥9.3b

7D

3.5%

1Y

-9.0%

Updated

05 Feb, 2025

Data

Company Financials +

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

XSEC:002317 Stock Report

Market Cap: CN¥9.3b

002317 Stock Overview

Guangdong Zhongsheng Pharmaceutical Co., Ltd. More details

002317 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Rewards

Earnings are forecast to grow 41.72% per year

Risk Analysis

Profit margins (5.4%) are lower than last year (12.8%)

Dividend of 1.82% is not well covered by earnings


My Notes

Capture your thoughts, links and company narrative

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Competitors

North China Pharmaceutical Company.Ltd

SHSE:600812

CN¥9.7b

Zhejiang Xianju PharmaceuticalLtd

SZSE:002332

CN¥9.8b

Zhejiang Wolwo Bio-Pharmaceutical

SZSE:300357

CN¥10.4b

Xiamen Kingdomway Group

SZSE:002626

CN¥8.7b

Price History & Performance

Summary of share price highs, lows and changes for Guangdong Zhongsheng Pharmaceutical
Historical stock prices
Current Share PriceCN¥10.99
52 Week HighCN¥18.42
52 Week LowCN¥10.56
Beta0.67
1 Month Change-16.04%
3 Month Change-18.35%
1 Year Change-9.02%
3 Year Change2.52%
5 Year Change-20.71%
Change since IPO-15.14%

Recent News & Updates

Recent updates

Shareholder Returns

002317CN PharmaceuticalsCN Market
7D3.5%0%0%
1Y-9.0%7.3%20.1%

Return vs Industry: 002317 underperformed the CN Pharmaceuticals industry which returned 7.3% over the past year.

Return vs Market: 002317 underperformed the CN Market which returned 20.1% over the past year.

Price Volatility

Is 002317's price volatile compared to industry and market?
002317 volatility
002317 Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement6.6%
10% most volatile stocks in CN Market10.7%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 002317 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002317's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a1,732Yong Hong Chenwww.zspcl.com

Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceuticals in China. The company offers Chinese and chemical medicines, raw materials, and intermediates. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Fundamentals Summary

How do Guangdong Zhongsheng Pharmaceutical's earnings and revenue compare to its market cap?
002317 fundamental statistics
Market capCN¥9.30b
Earnings (TTM)CN¥132.58m
Revenue (TTM)CN¥2.45b

70.1x

P/E Ratio

3.8x

P/S Ratio

Is 002317 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002317 income statement (TTM)
RevenueCN¥2.45b
Cost of RevenueCN¥1.10b
Gross ProfitCN¥1.35b
Other ExpensesCN¥1.22b
EarningsCN¥132.58m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 26, 2025

Earnings per share (EPS)0.16
Gross Margin55.11%
Net Profit Margin5.42%
Debt/Equity Ratio0%

How did 002317 perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

125%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/05 01:29
End of Day Share Price 2025/02/05 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guangdong Zhongsheng Pharmaceutical Co., Ltd. is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhi Xue DiaoAvic Securities Co., Ltd
Shanshan LiChina Merchants Securities Co. Ltd.
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)